Americans will soon be able to self-test at home to find out whether they have COVID-19, the flu or another common germ, respiratory syncytial virus (RSV).
May 18, 2022
0
2
If you recently had COVID-19, you may be wondering if you should delay getting your booster. We asked James Moy, MD, an immunologist in the Department of Internal Medicine at RUSH who is studying the antibody levels and duration ...
May 09, 2022
0
8
University of Texas at Dallas researchers have developed a rapid virus test using gold particles and lasers that promises to deliver results as accurate as lab tests in a fraction of the time.
May 04, 2022
0
105
A study recently completed at the University of Helsinki and published in Journal of Fungi revealed that the fungal microbiota in the gut is more abundant and diverse in children treated with antibiotics compared with the ...
Apr 29, 2022
0
5
Respiratory syncytial virus (RSV) is a leading cause of severe acute lower respiratory tract infections (LRTIs) among infants globally, and a prominent contributor to common non-severe infections that account for high volumes ...
Mar 14, 2022
0
55
Close interactions with infectious disease set both University of California, Santa Cruz graduate student Ana Nuñez Castrejon and Associate Professor of Biomolecular Engineering Rebecca DuBois on the path of studying respiratory ...
Mar 10, 2022
0
85
Nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled ...
Mar 02, 2022
0
788
Public health measures to control COVID, including social distancing, masks, border closures and reduced international travel, have worked to reduce the impact of COVID.
Mar 01, 2022
0
5
Concentrations of coronavirus in the Gothenburg area's wastewater are still decreasing. The latest measurements and analyses from the University of Gothenburg also show that BA.2, a subvariant of omicron, has rapidly become ...
Feb 22, 2022
0
27
Preclinical models that recapitulate aspects of human airway disease are essential for the advancement of novel therapeutics and vaccines. In the current study published in the journal mBIO, researchers at Baylor College ...
Feb 15, 2022
0
131
Human respiratory syncytial virus (RSV) causes respiratory tract infections. It is the major cause of lower respiratory tract infection and hospital visits during infancy and childhood. There is no vaccine, and the only treatment is oxygen.
In temperate climates there is an annual epidemic during the winter months. In tropical climates, infection is most common during the rainy season.
In the United States, 60% of infants are infected during their first RSV season, and nearly all children will have been infected with the virus by 2-3 years of age. Natural infection with RSV does not induce protective immunity, and thus people can be infected multiple times. Sometimes an infant can become symptomatically infected more than once even within a single RSV season. Severe RSV infections have increasingly been found among elderly patients.
RSV is a negative-sense, single-stranded RNA virus of the family Paramyxoviridae, which includes common respiratory viruses such as those causing measles and mumps. RSV is a member of the paramyxovirus subfamily Pneumovirinae. Its name comes from the fact that F proteins on the surface of the virus cause the cell membranes on nearby cells to merge, forming syncytia.
This text uses material from Wikipedia, licensed under CC BY-SA
